{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:45:14Z","timestamp":1790703914536,"version":"4.1.0"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1157281"],"award-info":[{"award-number":["GNT1157281"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Medical Research Future Fund","award":["MRF2007431"],"award-info":[{"award-number":["MRF2007431"]}],"id":[{"id":"https:\/\/ror.org\/0513v5k17","id-type":"ROR","asserted-by":"crossref"}]},{"name":"University of South Australia","id":[{"id":"https:\/\/ror.org\/01p93h210","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["GeroScience"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Sub-optimal metabolism is linked to dementia risk, yet metabolic traits rarely occur in isolation. Using data from 308,019 UK Biobank participants, we examined associations of six diverse metabolic subgroups (I\u2013VI)\n                    <jats:bold>\u2013<\/jats:bold>\n                    previously derived via a self-organising map (SOM) that captures patterns of co-occurring metabolic biomarker traits in the population\n                    <jats:bold>\u2013<\/jats:bold>\n                    and 39 individual biomarkers, with incident all-cause dementia, Alzheimer\u2019s disease (AD), and vascular dementia (VaD). Biomarker associations were assessed using both linear and nonlinear (restricted cubic spline) models. After adjusting for age, sex, socioeconomic, and lifestyle factors, subgroup analyses showed that participants in the two leanest and two most adipose subgroups had higher risk of dementia outcomes compared to others. Subgroups with high adiposity exhibited elevated VaD risk, which was linked to hypertension, hyperglycaemia, and liver stress (Subgroup II); inflammation, microalbuminuria, and low apolipoprotein A1 (III). For AD, the risk was elevated in the lean subgroups (IV, V), characterised by low body mass index (BMI), triglycerides, and urate, and high sex-hormone binding globulin; as well as for adipose Subgroup II.\n                    <jats:italic>APOE<\/jats:italic>\n                    -\u03b54 allele count had limited influence on dementia associations with metabolic subgroups and biomarkers. This marked metabolic heterogeneity in dementia risk suggests that metabolic profiling could inform targeted prevention strategies. Interpretation of these findings is supported by previously reported MRI profiles of the metabolic subgroups, providing biological context.\n                  <\/jats:p>","DOI":"10.1007\/s11357-025-01970-6","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T21:33:24Z","timestamp":1764365604000},"page":"6693-6717","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Dementia risk across distinct metabolic profiles in the UK Biobank"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0214-6498","authenticated-orcid":false,"given":"Amanda L.","family":"Lumsden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8018-3454","authenticated-orcid":false,"given":"Anwar","family":"Mulugeta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3670-9399","authenticated-orcid":false,"given":"Elina","family":"Hypp\u00f6nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"issue":"1","key":"1970_CR1","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1002\/alz.13439","volume":"20","author":"D Qureshi","year":"2024","unstructured":"Qureshi D, Collister J, Allen NE, Ku\u017ama E, Littlejohns T. Association between metabolic syndrome and risk of incident dementia in UK biobank. Alzheimers Dement. 2024;20(1):447\u201358. https:\/\/doi.org\/10.1002\/alz.13439.","journal-title":"Alzheimers Dement"},{"issue":"2","key":"1970_CR2","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/dom.15331","volume":"26","author":"A Kuate Defo","year":"2024","unstructured":"Kuate Defo A, Bakula V, Pisaturo A, Labos C, Wing SS, Daskalopoulou SS. Diabetes, antidiabetic medications and risk of dementia: a systematic umbrella review and meta-analysis. Diabetes Obes Metab. 2024;26(2):441\u201362. https:\/\/doi.org\/10.1111\/dom.15331.","journal-title":"Diabetes Obes Metab"},{"key":"1970_CR3","doi-asserted-by":"publisher","DOI":"10.12659\/msm.943417","volume":"30","author":"D Medina-Julio","year":"2024","unstructured":"Medina-Julio D, Ram\u00edrez-Mej\u00eda MM, Cordova-Gallardo J, Peniche-Luna E, Cant\u00fa-Brito C, Mendez-Sanchez N. From liver to brain: how MAFLD\/MASLD impacts cognitive function. Med Sci Monit. 2024;30:e943417. https:\/\/doi.org\/10.12659\/msm.943417.","journal-title":"Med Sci Monit"},{"issue":"1","key":"1970_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-023-01248-z","volume":"15","author":"TS Yeh","year":"2023","unstructured":"Yeh TS, Clifton L, Collister JA, Liu X, Hunter DJ, Littlejohns TJ. Kidney function, albuminuria, and their modification by genetic factors and risk of incident dementia in UK biobank. Alzheimers Res Ther. 2023;15(1):138. https:\/\/doi.org\/10.1186\/s13195-023-01248-z.","journal-title":"Alzheimers Res Ther"},{"key":"1970_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-11-177","volume":"11","author":"E Younesi","year":"2013","unstructured":"Younesi E, Hofmann-Apitius M. A network model of genomic hormone interactions underlying dementia and its translational validation through serendipitous off-target effect. J Transl Med. 2013;11:177. https:\/\/doi.org\/10.1186\/1479-5876-11-177.","journal-title":"J Transl Med"},{"key":"1970_CR6","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.neurobiolaging.2016.01.011","volume":"40","author":"JR Rettberg","year":"2016","unstructured":"Rettberg JR, Dang H, Hodis HN, et al. Identifying postmenopausal women at risk for cognitive decline within a healthy cohort using a panel of clinical metabolic indicators: potential for detecting an at-Alzheimer\u2019s risk metabolic phenotype. Neurobiol Aging. 2016;40:155\u201363. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2016.01.011.","journal-title":"Neurobiol Aging"},{"issue":"6","key":"1970_CR7","doi-asserted-by":"publisher","first-page":"485","DOI":"10.2174\/1570159x18666200123165652","volume":"18","author":"H Guo","year":"2020","unstructured":"Guo H, Liu M, Zhang L, et al. The critical period for neuroprotection by estrogen replacement therapy and the potential underlying mechanisms. Curr Neuropharmacol. 2020;18(6):485\u2013500. https:\/\/doi.org\/10.2174\/1570159x18666200123165652.","journal-title":"Curr Neuropharmacol"},{"key":"1970_CR8","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.neubiorev.2020.05.012","volume":"115","author":"Y Qu","year":"2020","unstructured":"Qu Y, Hu HY, Ou YN, et al. Association of body mass index with risk of cognitive impairment and dementia: a systematic review and meta-analysis of prospective studies. Neurosci Biobehav Rev. 2020;115:189\u201398. https:\/\/doi.org\/10.1016\/j.neubiorev.2020.05.012.","journal-title":"Neurosci Biobehav Rev"},{"key":"1970_CR9","doi-asserted-by":"publisher","first-page":"1095236","DOI":"10.3389\/fepid.2023.1095236","volume":"3","author":"J Brain","year":"2023","unstructured":"Brain J, Greene L, Tang EYH, et al. Cardiovascular disease, associated risk factors, and risk of dementia: an umbrella review of meta-analyses. Front Epidemiol. 2023;3:1095236. https:\/\/doi.org\/10.3389\/fepid.2023.1095236.","journal-title":"Front Epidemiol"},{"issue":"1","key":"1970_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-12198-1","volume":"12","author":"A Mulugeta","year":"2022","unstructured":"Mulugeta A, Hypp\u00f6nen E, Ala-Korpela M, M\u00e4kinen VP. Cross-sectional metabolic subgroups and 10-year follow-up of cardiometabolic multimorbidity in the UK biobank. Sci Rep. 2022;12(1):8590. https:\/\/doi.org\/10.1038\/s41598-022-12198-1.","journal-title":"Sci Rep"},{"key":"1970_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2022.155342","volume":"138","author":"M Ahmed","year":"2023","unstructured":"Ahmed M, M\u00e4kinen VP, Lumsden A, et al. Metabolic profile predicts incident cancer: a large-scale population study in the UK biobank. Metabolism. 2023;138:155342. https:\/\/doi.org\/10.1016\/j.metabol.2022.155342.","journal-title":"Metabolism"},{"issue":"1","key":"1970_CR12","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/dom.14853","volume":"25","author":"AL Lumsden","year":"2023","unstructured":"Lumsden AL, Mulugeta A, M\u00e4kinen VP, Hypp\u00f6nen E. Metabolic profile-based subgroups can identify differences in brain volumes and brain iron deposition. Diabetes Obes Metab. 2023;25(1):121\u201331. https:\/\/doi.org\/10.1111\/dom.14853.","journal-title":"Diabetes Obes Metab"},{"issue":"3","key":"1970_CR13","doi-asserted-by":"publisher","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","volume":"12","author":"C Sudlow","year":"2015","unstructured":"Sudlow C, Gallacher J, Allen N, et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015;12(3):e1001779. https:\/\/doi.org\/10.1371\/journal.pmed.1001779.","journal-title":"PLoS Med"},{"issue":"3","key":"1970_CR14","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/s40120-023-00458-9","volume":"12","author":"Y Zou","year":"2023","unstructured":"Zou Y, Wang Q, Cheng X. Causal relationship between basal metabolic rate and Alzheimer\u2019s disease: a bidirectional two-sample Mendelian randomization study. Neurol Ther. 2023;12(3):763\u201376. https:\/\/doi.org\/10.1007\/s40120-023-00458-9.","journal-title":"Neurol Ther"},{"issue":"6937","key":"1970_CR15","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1136\/bmj.308.6937.1125","volume":"308","author":"P Phillimore","year":"1994","unstructured":"Phillimore P, Beattie A, Townsend P. Widening inequality of health in northern England, 1981\u201391. BMJ. 1994;308(6937):1125\u20138. https:\/\/doi.org\/10.1136\/bmj.308.6937.1125.","journal-title":"BMJ"},{"issue":"3","key":"1970_CR16","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/ng.3768","volume":"49","author":"HR Warren","year":"2017","unstructured":"Warren HR, Evangelou E, Cabrera CP, et al. Genome-wide association analysis identifies novel blood pressure loci and offers biological insights into cardiovascular risk. Nat Genet. 2017;49(3):403\u201315. https:\/\/doi.org\/10.1038\/ng.3768.","journal-title":"Nat Genet"},{"key":"1970_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102954","volume":"59","author":"AL Lumsden","year":"2020","unstructured":"Lumsden AL, Mulugeta A, Zhou A, Hypponen E. Apolipoprotein E (APOE) genotype-associated disease risks: a phenome-wide, registry-based, case-control study utilising the UK Biobank. EBioMedicine. 2020;59:102954. https:\/\/doi.org\/10.1016\/j.ebiom.2020.102954.","journal-title":"EBioMedicine"},{"key":"1970_CR18","doi-asserted-by":"crossref","unstructured":"Harrell FE Jr. Regression Modeling Strategies: With applications to linear models, logistic and ordinal regression, and survival analysis. 2nd ed. Cham: Springer; 2015. https:\/\/link.springer.com\/book\/10.1007\/978-3-319-19425-7.","DOI":"10.1007\/978-3-319-19425-7"},{"issue":"2","key":"1970_CR19","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1093\/ije\/dyt034","volume":"42","author":"TA Khan","year":"2013","unstructured":"Khan TA, Shah T, Prieto D, et al. Apolipoprotein E genotype, cardiovascular biomarkers and risk of stroke: systematic review and meta-analysis of 14,015 stroke cases and pooled analysis of primary biomarker data from up to 60,883 individuals. Int J Epidemiol. 2013;42(2):475\u201392. https:\/\/doi.org\/10.1093\/ije\/dyt034.","journal-title":"Int J Epidemiol"},{"key":"1970_CR20","doi-asserted-by":"publisher","DOI":"10.1017\/s2045796020000347","volume":"29","author":"JQ Thomassen","year":"2020","unstructured":"Thomassen JQ, Tolstrup JS, Benn M, Frikke-Schmidt R. Type-2 diabetes and risk of dementia: observational and Mendelian randomisation studies in 1 million individuals. Epidemiol Psychiatr Sci. 2020;29:e118. https:\/\/doi.org\/10.1017\/s2045796020000347.","journal-title":"Epidemiol Psychiatr Sci"},{"issue":"4","key":"1970_CR21","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/s2213-8587(19)30405-x","volume":"8","author":"TT van Sloten","year":"2020","unstructured":"van Sloten TT, Sedaghat S, Carnethon MR, Launer LJ, Stehouwer CDA. Cerebral microvascular complications of type 2 diabetes: stroke, cognitive dysfunction, and depression. Lancet Diabetes Endocrinol. 2020;8(4):325\u201336. https:\/\/doi.org\/10.1016\/s2213-8587(19)30405-x.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"1970_CR22","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/ajh.2009.212","volume":"23","author":"M Nagai","year":"2010","unstructured":"Nagai M, Hoshide S, Kario K. Hypertension and dementia. Am J Hypertens. 2010;23(2):116\u201324. https:\/\/doi.org\/10.1038\/ajh.2009.212.","journal-title":"Am J Hypertens"},{"key":"1970_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2023.108575","volume":"253","author":"M Lyon","year":"2024","unstructured":"Lyon M, Fullerton JL, Kennedy S, Work LM. Hypertension & dementia: pathophysiology & potential utility of antihypertensives in reducing disease burden. Pharmacol Ther. 2024;253:108575. https:\/\/doi.org\/10.1016\/j.pharmthera.2023.108575.","journal-title":"Pharmacol Ther"},{"issue":"1","key":"1970_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-63803-0","volume":"10","author":"E Han","year":"2020","unstructured":"Han E, Lee JY, Han KD, et al. Gamma glutamyltransferase and risk of dementia in prediabetes and diabetes. Sci Rep. 2020;10(1):6800. https:\/\/doi.org\/10.1038\/s41598-020-63803-0.","journal-title":"Sci Rep"},{"issue":"4","key":"1970_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0302209","volume":"19","author":"M Lingyu","year":"2024","unstructured":"Lingyu M, Hongguang L, Mingdong Z, Na L, Yahui L. Aminotransferases as causal factors for metabolic syndrome: a bidirectional Mendelian randomization study. PLoS ONE. 2024;19(4):e0302209. https:\/\/doi.org\/10.1371\/journal.pone.0302209.","journal-title":"PLoS ONE"},{"issue":"8","key":"1970_CR26","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.2337\/db18-1048","volume":"68","author":"NMG De Silva","year":"2019","unstructured":"De Silva NMG, Borges MC, Hingorani AD, et al. Liver function and risk of type 2 diabetes: bidirectional Mendelian randomization study. Diabetes. 2019;68(8):1681\u201391. https:\/\/doi.org\/10.2337\/db18-1048.","journal-title":"Diabetes"},{"issue":"1","key":"1970_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0296894","volume":"19","author":"Y Li","year":"2024","unstructured":"Li Y, Zhang Q. Causal associations between liver enzymes and diabetic microvascular complications: a univariable and multivariable Mendelian randomization. PLoS ONE. 2024;19(1):e0296894. https:\/\/doi.org\/10.1371\/journal.pone.0296894.","journal-title":"PLoS ONE"},{"issue":"2","key":"1970_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001383","volume":"10","author":"KS Vimaleswaran","year":"2013","unstructured":"Vimaleswaran KS, Berry DJ, Lu C, et al. Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts. PLoS Med. 2013;10(2):e1001383. https:\/\/doi.org\/10.1371\/journal.pmed.1001383.","journal-title":"PLoS Med"},{"issue":"8","key":"1970_CR29","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1042\/bcj20170042","volume":"474","author":"MJ Berridge","year":"2017","unstructured":"Berridge MJ. Vitamin D deficiency and diabetes. Biochem J. 2017;474(8):1321\u201332. https:\/\/doi.org\/10.1042\/bcj20170042.","journal-title":"Biochem J"},{"issue":"51","key":"1970_CR30","doi-asserted-by":"publisher","first-page":"e23672","DOI":"10.1097\/md.0000000000023672","volume":"99","author":"Y Xu","year":"2020","unstructured":"Xu Y, Zhou Y, Liu J, et al. Genetically increased circulating 25(OH)D level reduces the risk of type 2 diabetes in subjects with deficiency of vitamin D: a large-scale Mendelian randomization study. Medicine (Baltimore). 2020;99(51):e23672. https:\/\/doi.org\/10.1097\/md.0000000000023672.","journal-title":"Medicine (Baltimore)"},{"key":"1970_CR31","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1159\/000517698","volume":"199","author":"DM Kelly","year":"2021","unstructured":"Kelly DM, Kelleher EM, Sood MM. Stroke and chronic kidney disease. Contrib Nephrol. 2021;199:80\u201390. https:\/\/doi.org\/10.1159\/000517698.","journal-title":"Contrib Nephrol"},{"key":"1970_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.770184","volume":"9","author":"CS Wei","year":"2022","unstructured":"Wei CS, Yan CY, Yu XR, et al. Association between white matter hyperintensities and chronic kidney disease: a systematic review and meta-analysis. Front Med. 2022;9:770184. https:\/\/doi.org\/10.3389\/fmed.2022.770184.","journal-title":"Front Med"},{"issue":"1","key":"1970_CR33","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s12975-016-0499-x","volume":"8","author":"WL Lau","year":"2017","unstructured":"Lau WL, Huisa BN, Fisher M. The cerebrovascular-chronic kidney disease connection: perspectives and mechanisms. Transl Stroke Res. 2017;8(1):67\u201376. https:\/\/doi.org\/10.1007\/s12975-016-0499-x.","journal-title":"Transl Stroke Res"},{"issue":"2","key":"1970_CR34","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1159\/000528693","volume":"9","author":"J Li","year":"2023","unstructured":"Li J, Chen J, Lan HY, Tang Y. Role of c-reactive protein in kidney diseases. Kidney Dis. 2023;9(2):73\u201381. https:\/\/doi.org\/10.1159\/000528693.","journal-title":"Kidney Dis"},{"issue":"12","key":"1970_CR35","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1586\/erc.11.159","volume":"9","author":"M Di Napoli","year":"2011","unstructured":"Di Napoli M, Elkind MS, Godoy DA, Singh P, Papa F, Popa-Wagner A. Role of C-reactive protein in cerebrovascular disease: a critical review. Expert Rev Cardiovasc Ther. 2011;9(12):1565\u201384. https:\/\/doi.org\/10.1586\/erc.11.159.","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"1","key":"1970_CR36","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1159\/000092960","volume":"22","author":"Y Davidson","year":"2006","unstructured":"Davidson Y, Gibbons L, Purandare N, Byrne J, Hardicre J, Wren J, et al. Apolipoprotein E epsilon4 allele frequency in vascular dementia. Dement Geriatr Cogn Disord. 2006;22(1):15\u20139. https:\/\/doi.org\/10.1159\/000092960.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"23","key":"1970_CR37","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1001\/jama.293.23.2892","volume":"293","author":"CC Hsu","year":"2005","unstructured":"Hsu CC, Kao WH, Coresh J, Pankow JS, Marsh-Manzi J, Boerwinkle E, et al. Apolipoprotein E and progression of chronic kidney disease. JAMA. 2005;293(23):2892\u20139. https:\/\/doi.org\/10.1001\/jama.293.23.2892.","journal-title":"JAMA"},{"key":"1970_CR38","doi-asserted-by":"publisher","first-page":"1233601","DOI":"10.3389\/fnins.2023.1233601","volume":"17","author":"H Xue","year":"2023","unstructured":"Xue H, Zeng L, Liu S. Unraveling the link: exploring the causal relationship between diabetes, multiple sclerosis, migraine, and Alzheimer\u2019s disease through Mendelian randomization. Front Neurosci. 2023;17:1233601. https:\/\/doi.org\/10.3389\/fnins.2023.1233601.","journal-title":"Front Neurosci"},{"issue":"10","key":"1970_CR39","doi-asserted-by":"publisher","first-page":"4367","DOI":"10.1002\/alz.13373","volume":"19","author":"EM Litkowski","year":"2023","unstructured":"Litkowski EM, Logue MW, Zhang R, et al. Mendelian randomization study of diabetes and dementia in the Million Veteran Program. Alzheimers Dement. 2023;19(10):4367\u201376. https:\/\/doi.org\/10.1002\/alz.13373.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"1970_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-022-00768-9","volume":"12","author":"L Meng","year":"2022","unstructured":"Meng L, Wang Z, Ji HF, Shen L. Causal association evaluation of diabetes with Alzheimer\u2019s disease and genetic analysis of antidiabetic drugs against Alzheimer\u2019s disease. Cell Biosci. 2022;12(1):28. https:\/\/doi.org\/10.1186\/s13578-022-00768-9.","journal-title":"Cell Biosci"},{"issue":"2","key":"1970_CR41","doi-asserted-by":"publisher","first-page":"609","DOI":"10.3233\/JAD-190713","volume":"73","author":"L Wang","year":"2020","unstructured":"Wang L, Qiao Y, Zhang H, et al. Circulating vitamin D levels and Alzheimer\u2019s disease: a Mendelian randomization study in the IGAP and UK Biobank. J Alzheimers Dis. 2020;73(2):609\u201318. https:\/\/doi.org\/10.3233\/JAD-190713.","journal-title":"J Alzheimers Dis"},{"key":"1970_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/nu10091243","author":"SC Larsson","year":"2018","unstructured":"Larsson SC, Traylor M, Markus HS, Michaelsson K. Serum parathyroid hormone, 25-hydroxyvitamin D, and risk of Alzheimer\u2019s disease: a mendelian randomization study. Nutrients. 2018. https:\/\/doi.org\/10.3390\/nu10091243.","journal-title":"Nutrients"},{"issue":"9","key":"1970_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001713","volume":"11","author":"P Proitsi","year":"2014","unstructured":"Proitsi P, Lupton MK, Velayudhan L, et al. Genetic predisposition to increased blood cholesterol and triglyceride lipid levels and risk of Alzheimer disease: a Mendelian randomization analysis. PLoS Med. 2014;11(9):e1001713. https:\/\/doi.org\/10.1371\/journal.pmed.1001713.","journal-title":"PLoS Med"},{"issue":"7","key":"1970_CR44","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s10654-023-01015-2","volume":"38","author":"CHC Yeung","year":"2023","unstructured":"Yeung CHC, Au Yeung SL, Kwok MK, Zhao JV, Schooling CM. The influence of growth and sex hormones on risk of Alzheimer\u2019s disease: a mendelian randomization study. Eur J Epidemiol. 2023;38(7):745\u201355. https:\/\/doi.org\/10.1007\/s10654-023-01015-2.","journal-title":"Eur J Epidemiol"},{"issue":"2","key":"1970_CR45","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3233\/jad-210345","volume":"82","author":"X Li","year":"2021","unstructured":"Li X, Tian Y, Yang YX, et al. Life course adiposity and Alzheimer\u2019s disease: a Mendelian randomization study. J Alzheimers Dis. 2021;82(2):503\u201312. https:\/\/doi.org\/10.3233\/jad-210345.","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"1970_CR46","doi-asserted-by":"publisher","first-page":"e2313734","DOI":"10.1001\/jamanetworkopen.2023.13734","volume":"6","author":"J Luo","year":"2023","unstructured":"Luo J, Thomassen JQ, Bellenguez C, et al. Genetic associations between modifiable risk factors and Alzheimer disease. JAMA Netw Open. 2023;6(5):e2313734. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.13734.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"1970_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-023-01692-8","volume":"16","author":"B Li","year":"2023","unstructured":"Li B, Qu Y, Fan Z, et al. Causal relationships between blood lipids and major psychiatric disorders: univariable and multivariable mendelian randomization analysis. BMC Med Genomics. 2023;16(1):250. https:\/\/doi.org\/10.1186\/s12920-023-01692-8.","journal-title":"BMC Med Genomics"},{"key":"1970_CR48","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2009808118","author":"J Lord","year":"2021","unstructured":"Lord J, Jermy B, Green R, et al. Mendelian randomization identifies blood metabolites previously linked to midlife cognition as causal candidates in Alzheimer\u2019s disease. Proc Natl Acad Sci U S A. 2021. https:\/\/doi.org\/10.1073\/pnas.2009808118.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"21","key":"1970_CR49","doi-asserted-by":"publisher","first-page":"21747","DOI":"10.18632\/aging.103983","volume":"12","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, Xu F, Wang L, Zhang WD, Sun CQ, Deng HW. Detecting potential causal relationship between multiple risk factors and Alzheimer\u2019s disease using multivariable Mendelian randomization. Aging (Albany NY). 2020;12(21):21747\u201357. https:\/\/doi.org\/10.18632\/aging.103983.","journal-title":"Aging (Albany NY)"},{"key":"1970_CR50","doi-asserted-by":"publisher","first-page":"j5375","DOI":"10.1136\/bmj.j5375","volume":"359","author":"SC Larsson","year":"2017","unstructured":"Larsson SC, Traylor M, Malik R, et al. Modifiable pathways in Alzheimer\u2019s disease: Mendelian randomisation analysis. BMJ. 2017;359:j5375. https:\/\/doi.org\/10.1136\/bmj.j5375.","journal-title":"BMJ."},{"issue":"5","key":"1970_CR51","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1093\/cvr\/cvab164","volume":"118","author":"EW Kjeldsen","year":"2022","unstructured":"Kjeldsen EW, Thomassen JQ, Juul Rasmussen I, Nordestgaard BG, Tybj\u00e6rg-Hansen A, Frikke-Schmidt R. Plasma high-density lipoprotein cholesterol and risk of dementia: observational and genetic studies. Cardiovasc Res. 2022;118(5):1330\u201343. https:\/\/doi.org\/10.1093\/cvr\/cvab164.","journal-title":"Cardiovasc Res"},{"issue":"2","key":"1970_CR52","doi-asserted-by":"publisher","first-page":"725","DOI":"10.3233\/jad-230623","volume":"96","author":"Q He","year":"2023","unstructured":"He Q, Wang W, Li H, et al. Genetic insights into the risk of metabolic syndrome and its components on dementia: a Mendelian randomization. J Alzheimers Dis. 2023;96(2):725\u201343. https:\/\/doi.org\/10.3233\/jad-230623.","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"1970_CR53","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.3233\/jad-220649","volume":"89","author":"YN Ou","year":"2022","unstructured":"Ou YN, Zhao B, Fu Y, et al. The association of serum uric acid level, gout, and Alzheimer\u2019s disease: a bidirectional Mendelian randomization study. J Alzheimers Dis. 2022;89(3):1063\u201373. https:\/\/doi.org\/10.3233\/jad-220649.","journal-title":"J Alzheimers Dis"},{"key":"1970_CR54","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.neurobiolaging.2022.09.004","volume":"120","author":"BA \u015eanl\u0131","year":"2022","unstructured":"\u015eanl\u0131 BA, Whittaker KJ, Motsi GK, Shen E, Julian TH, Cooper-Knock J. Unbiased metabolome screen links serum urate to risk of Alzheimer\u2019s disease. Neurobiol Aging. 2022;120:167\u201376. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2022.09.004.","journal-title":"Neurobiol Aging"},{"key":"1970_CR55","doi-asserted-by":"publisher","DOI":"10.1080\/1028415x.2024.2352195","author":"Z Yin","year":"2024","unstructured":"Yin Z, Yang Z, Liu Y, Zhao L, Liang F. Oxidative stress and neurodegenerative diseases: a bidirectional Mendelian randomization study. Nutr Neurosci. 2024. https:\/\/doi.org\/10.1080\/1028415x.2024.2352195.","journal-title":"Nutr Neurosci"},{"issue":"1","key":"1970_CR56","doi-asserted-by":"publisher","DOI":"10.1136\/bmjmed-2022-000354","volume":"2","author":"I Daghlas","year":"2023","unstructured":"Daghlas I, Nassan M, Gill D. Genetically proxied lean mass and risk of Alzheimer\u2019s disease: mendelian randomisation study. BMJ Med. 2023;2(1):e000354. https:\/\/doi.org\/10.1136\/bmjmed-2022-000354.","journal-title":"BMJ Med"},{"issue":"11","key":"1970_CR57","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1002\/alz.12568","volume":"18","author":"SH Hegazy","year":"2022","unstructured":"Hegazy SH, Thomassen JQ, Rasmussen IJ, Nordestgaard BG, Tybjaerg-Hansen A, Frikke-Schmidt R. C-reactive protein levels and risk of dementia-observational and genetic studies of 111,242 individuals from the general population. Alzheimers Dement. 2022;18(11):2262\u201371. https:\/\/doi.org\/10.1002\/alz.12568.","journal-title":"Alzheimers Dement"},{"issue":"10","key":"1970_CR58","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1002\/alz.12688","volume":"18","author":"J Luo","year":"2022","unstructured":"Luo J, Thomassen JQ, Hegazy SH, et al. Reply to \u201cMendelian randomization highlights causal association between genetically increased C-reactive protein levels and reduced Alzheimer\u2019s disease risk.\u201d Alzheimers Dement. 2022;18(10):2007\u20139. https:\/\/doi.org\/10.1002\/alz.12688.","journal-title":"Alzheimers Dement"},{"issue":"10","key":"1970_CR59","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1002\/alz.12687","volume":"18","author":"Y Hu","year":"2022","unstructured":"Hu Y, Zhang Y, Zhang H, et al. Mendelian randomization highlights causal association between genetically increased C-reactive protein levels and reduced Alzheimer\u2019s disease risk. Alzheimers Dement. 2022;18(10):2003\u20136. https:\/\/doi.org\/10.1002\/alz.12687.","journal-title":"Alzheimers Dement"},{"key":"1970_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2023.106365","volume":"157","author":"T Amorim","year":"2023","unstructured":"Amorim T, Khiyami A, Latif T, Fazeli PK. Neuroendocrine adaptations to starvation. Psychoneuroendocrinology. 2023;157:106365. https:\/\/doi.org\/10.1016\/j.psyneuen.2023.106365.","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"1970_CR61","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.mce.2010.04.005","volume":"335","author":"AE Coutinho","year":"2011","unstructured":"Coutinho AE, Chapman KE. The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights. Mol Cell Endocrinol. 2011;335(1):2\u201313. https:\/\/doi.org\/10.1016\/j.mce.2010.04.005.","journal-title":"Mol Cell Endocrinol"},{"key":"1970_CR62","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3389\/fnagi.2019.00043","volume":"11","author":"S Ouanes","year":"2019","unstructured":"Ouanes S, Popp J. High cortisol and the risk of dementia and Alzheimer\u2019s disease: a review of the literature. Front Aging Neurosci. 2019;11:43. https:\/\/doi.org\/10.3389\/fnagi.2019.00043.","journal-title":"Front Aging Neurosci"},{"issue":"8","key":"1970_CR63","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1212\/WNL.56.8.1094","volume":"56","author":"ER Peskind","year":"2001","unstructured":"Peskind ER, Wilkinson CW, Petrie EC, Schellenberg GD, Raskind MA. Increased CSF cortisol in AD is a function of APOE genotype. Neurology. 2001;56(8):1094\u20138. https:\/\/doi.org\/10.1212\/WNL.56.8.1094.","journal-title":"Neurology"},{"issue":"4","key":"1970_CR64","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1159\/000508625","volume":"49","author":"KA Jellinger","year":"2020","unstructured":"Jellinger KA. Pathobiological subtypes of Alzheimer disease. Dement Geriatr Cogn Disord. 2020;49(4):321\u201333. https:\/\/doi.org\/10.1159\/000508625.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"10","key":"1970_CR65","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1212\/wnl.0000000000009058","volume":"94","author":"D Ferreira","year":"2020","unstructured":"Ferreira D, Nordberg A, Westman E. Biological subtypes of Alzheimer disease: a systematic review and meta-analysis. Neurology. 2020;94(10):436\u201348. https:\/\/doi.org\/10.1212\/wnl.0000000000009058.","journal-title":"Neurology"},{"issue":"2","key":"1970_CR66","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1002\/mrm.22263","volume":"63","author":"MJ House","year":"2010","unstructured":"House MJ, St Pierre TG, Milward EA, Bruce DG, Olynyk JK. Relationship between brain R(2) and liver and serum iron concentrations in elderly men. Magn Reson Med. 2010;63(2):275\u201381. https:\/\/doi.org\/10.1002\/mrm.22263.","journal-title":"Magn Reson Med"},{"issue":"12","key":"1970_CR67","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1177\/2040622318788485","volume":"9","author":"DE Hosking","year":"2018","unstructured":"Hosking DE, Ayton S, Beckett N, Booth A, Peters R. More evidence is needed. Iron, incident cognitive decline and dementia: a systematic review. Ther Adv Chronic Dis. 2018;9(12):241\u201356. https:\/\/doi.org\/10.1177\/2040622318788485.","journal-title":"Ther Adv Chronic Dis"},{"key":"1970_CR68","doi-asserted-by":"publisher","first-page":"533","DOI":"10.3389\/fnins.2018.00533","volume":"12","author":"AL Lumsden","year":"2018","unstructured":"Lumsden AL, Rogers JT, Majd S, et al. Dysregulation of neuronal iron homeostasis as an alternative unifying effect of mutations causing familial Alzheimer\u2019s disease. Front Neurosci. 2018;12:533. https:\/\/doi.org\/10.3389\/fnins.2018.00533.","journal-title":"Front Neurosci"},{"issue":"9","key":"1970_CR69","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.1002\/alz.13088","volume":"19","author":"YX Qiang","year":"2023","unstructured":"Qiang YX, Deng YT, Zhang YR, et al. Associations of blood cell indices and anemia with risk of incident dementia: a prospective cohort study of 313,448 participants. Alzheimers Dement. 2023;19(9):3965\u201376. https:\/\/doi.org\/10.1002\/alz.13088.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"1970_CR70","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-018-0556-z","volume":"10","author":"LM Winchester","year":"2018","unstructured":"Winchester LM, Powell J, Lovestone S, Nevado-Holgado AJ. Red blood cell indices and anaemia as causative factors for cognitive function deficits and for Alzheimer\u2019s disease. Genome Med. 2018;10(1):51. https:\/\/doi.org\/10.1186\/s13073-018-0556-z.","journal-title":"Genome Med"},{"issue":"4","key":"1970_CR71","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1002\/jcsm.13277","volume":"14","author":"JSJ Vinke","year":"2023","unstructured":"Vinke JSJ, Gorter AR, Eisenga MF, et al. Iron deficiency is related to lower muscle mass in community-dwelling individuals and impairs myoblast proliferation. J Cachexia Sarcopenia Muscle. 2023;14(4):1865\u201379. https:\/\/doi.org\/10.1002\/jcsm.13277.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"1970_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2021.111379","volume":"150","author":"SH Tseng","year":"2021","unstructured":"Tseng SH, Lee WJ, Peng LN, Lin MH, Chen LK. Associations between hemoglobin levels and sarcopenia and its components: results from the I-Lan longitudinal study. Exp Gerontol. 2021;150:111379. https:\/\/doi.org\/10.1016\/j.exger.2021.111379.","journal-title":"Exp Gerontol"},{"issue":"14","key":"1970_CR73","doi-asserted-by":"publisher","first-page":"e2400020","DOI":"10.1002\/mnfr.202400020","volume":"68","author":"L Brianso-Llort","year":"2024","unstructured":"Brianso-Llort L, Sa\u00e9z-Lopez C, Alvarez-Guaita A, Ramos-Perez L, Hernandez C, Sim\u00f3 R, et al. Recent advances on sex hormone-binding globulin regulation by nutritional factors: clinical implications. Mol Nutr Food Res. 2024;68(14):e2400020. https:\/\/doi.org\/10.1002\/mnfr.202400020.","journal-title":"Mol Nutr Food Res"},{"key":"1970_CR74","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-025-01833-0","author":"BL McNeish","year":"2025","unstructured":"McNeish BL, Miljkovic I, Liu-Ambrose T, Ambrosio F, Esser K, Fahnestock M, et al. Muscle-brain crosstalk as a driver of brain health in aging. Geroscience. 2025. https:\/\/doi.org\/10.1007\/s11357-025-01833-0.","journal-title":"Geroscience"},{"issue":"12","key":"1970_CR75","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1016\/j.neurobiolaging.2007.04.018","volume":"29","author":"CM Brown","year":"2008","unstructured":"Brown CM, Choi E, Xu Q, Vitek MP, Colton CA. The APOE4 genotype alters the response of microglia and macrophages to 17\u03b2-estradiol. Neurobiol Aging. 2008;29(12):1783\u201394. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2007.04.018.","journal-title":"Neurobiol Aging"},{"key":"1970_CR76","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.neulet.2013.12.032","volume":"560","author":"J Kunzler","year":"2014","unstructured":"Kunzler J, Youmans KL, Yu C, Ladu MJ, Tai LM. APOE modulates the effect of estrogen therapy on A\u03b2 accumulation EFAD-Tg mice. Neurosci Lett. 2014;560:131\u20136. https:\/\/doi.org\/10.1016\/j.neulet.2013.12.032.","journal-title":"Neurosci Lett"},{"issue":"1","key":"1970_CR77","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-024-02834-x","volume":"14","author":"R Panitch","year":"2024","unstructured":"Panitch R, Sahelijo N, Hu J, et al. APOE genotype-specific methylation patterns are linked to Alzheimer disease pathology and estrogen response. Transl Psychiatry. 2024;14(1):129. https:\/\/doi.org\/10.1038\/s41398-024-02834-x.","journal-title":"Transl Psychiatry"},{"key":"1970_CR78","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.brainres.2010.12.074","volume":"1379","author":"V Thornton","year":"2011","unstructured":"Thornton V, Warden D, Talbot C, Mastana SS, Bandelow S, Hogervorst E. Modification of estrogen\u2019s association with Alzheimer\u2019s disease risk by genetic polymorphisms. Brain Res. 2011;1379:213\u201323. https:\/\/doi.org\/10.1016\/j.brainres.2010.12.074.","journal-title":"Brain Res"},{"issue":"1","key":"1970_CR79","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-022-03621-2","volume":"20","author":"S Yuan","year":"2022","unstructured":"Yuan S, Wu W, Ma W, et al. Body mass index, genetic susceptibility, and Alzheimer\u2019s disease: a longitudinal study based on 475,813 participants from the UK Biobank. J Transl Med. 2022;20(1):417. https:\/\/doi.org\/10.1186\/s12967-022-03621-2.","journal-title":"J Transl Med"},{"issue":"10","key":"1970_CR80","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1093\/aje\/kwab103","volume":"190","author":"WD Brenowitz","year":"2021","unstructured":"Brenowitz WD, Zimmerman SC, Filshtein TJ, et al. Extension of Mendelian randomization to identify earliest manifestations of Alzheimer disease: association of genetic risk score for Alzheimer disease with lower body mass index by age 50 years. Am J Epidemiol. 2021;190(10):2163\u201371. https:\/\/doi.org\/10.1093\/aje\/kwab103.","journal-title":"Am J Epidemiol"},{"issue":"8","key":"1970_CR81","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1093\/aje\/kwad090","volume":"192","author":"LP Rojas-Saunero","year":"2023","unstructured":"Rojas-Saunero LP, Young JG, Didelez V, Ikram MA, Swanson SA. Considering questions before methods in dementia research with competing events and causal goals. Am J Epidemiol. 2023;192(8):1415\u201323. https:\/\/doi.org\/10.1093\/aje\/kwad090.","journal-title":"Am J Epidemiol"},{"issue":"9","key":"1970_CR82","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1093\/aje\/kwx246","volume":"186","author":"A Fry","year":"2017","unstructured":"Fry A, Littlejohns TJ, Sudlow C, et al. Comparison of sociodemographic and health-related characteristics of UK biobank participants with those of the general population. Am J Epidemiol. 2017;186(9):1026\u201334. https:\/\/doi.org\/10.1093\/aje\/kwx246.","journal-title":"Am J Epidemiol"}],"updated-by":[{"DOI":"10.1007\/s11357-026-02114-0","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000}}],"container-title":["GeroScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-025-01970-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11357-025-01970-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-025-01970-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T17:02:50Z","timestamp":1790182970000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11357-025-01970-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":82,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["1970"],"URL":"https:\/\/doi.org\/10.1007\/s11357-025-01970-6","relation":{},"ISSN":["2509-2723"],"issn-type":[{"value":"2509-2723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,28]]},"assertion":[{"value":"1 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised due to errors in the main body text.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s11357-026-02114-0","URL":"https:\/\/doi.org\/10.1007\/s11357-026-02114-0","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no conflicts of interest to declare. Author disclosures are available in the supporting information.","order":1,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}